SCHEMBL1156570

SCHEMBL1156570

CC(C)(C)CN(Cc1cc(-c2ccsc2)n(S(=O)(=O)c2cccc(Cl)c2)c1)C(=O)O

nearest known ligand 0.35

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.35
HSD11B1 P28845 1/20 0.35
PTGDR2 Q9Y5Y4 1/20 0.34
SLC16A3 O15427 1/20 0.34
SLC16A1 P53985 1/20 0.34
MCTS1 Q9ULC4 1/20 0.34
HTR6 P50406 4/20 0.33
CHRM5 P08912 2/20 0.33
BCL9 O00512 1/20 0.33
CTNNB1 P35222 1/20 0.33
PTGER2 P43116 1/20 0.33
ALDH1A1 P00352 1/20 0.33
CTSL P07711 1/20 0.33
CTSS P25774 1/20 0.33
HCRTR2 O43614 1/20 0.33
TAS2R14 Q9NYV8 1/20 0.33
IDH2 P48735 1/20 0.33
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1156772 0.87 AOC3 (0.39) PTGDR2HTR6BCL9CTNNB1ALDH1A1
SCHEMBL1156912 0.86 L3MBTL1 (0.39) LMNAHSD11B1PTGDR2HTR6KMT2A
SCHEMBL1156472 0.85 PTGER2 (0.36) PTGDR2SLC16A3SLC16A1MCTS1PTGER2
SCHEMBL1157096 0.85 SLC1A3 (0.36) LMNAPTGDR2CHRM5ALDH1A1TAS2R14
SCHEMBL1156569 0.82 SLC16A3 (0.37) SLC16A3SLC16A1MCTS1HTR6BCL9
SCHEMBL1156564 0.82 LMNA (0.41) LMNAHSD11B1PTGDR2HTR6CHRM5
SCHEMBL1156567 0.79 SLC1A3 (0.34) PTGDR2SLC16A3SLC16A1MCTS1HTR6
SCHEMBL1762992 0.78 PRMT6 (0.44) HSD11B1HTR6ALDH1A1MEN1KMT2A
SCHEMBL1156777 0.78 AKR1C3 (0.37) HTR6ALDH1A1IDH2MEN1KMT2A
Hydrochloric Acid SCHEMBL1156568 0.77 PRMT6 (0.44) HTR6ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8048909-B2 Proton pump inhibitors TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-11-01 US disclosed
EP-2336107-A2 Proton pump inhibitors Takeda Pharmaceutical Company Limited (JP) 2011-06-22 EP disclosed
US-20110028476-A1 PROTON PUMP INHIBITORS KAJINO MASAHIRO 2011-02-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110028476-A1 PROTON PUMP INHIBITORS HRH2, HRH4, CYP2C19 LMNA 3735/4885HSD11B1 1088/4885PTGDR2 606/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.